Exogenous ketones as a metabolic intervention for Parkinson’s disease

Exogenous ketones as a metabolic intervention for Parkinson’s disease

<p>Neurodegenerative and neurological diseases are metabolic diseases that invite metabolic treatments. Nutritional interventions that induce a state of ketosis, or “ketogenics,” are one class of metabolic treatment that have the potential to address the root pathologies of such diseases. Pr...

Fuld beskrivelse

Bibliografiske detaljer
Hovedforfatter:	Norwitz, N
Andre forfattere:	Clarke, K
Format:	Thesis
Sprog:	English
Udgivet:	2020
Fag:	Metabolism Neurodegenerative diseases

Lignende værker

Metabolism of exogenous ketones
af: Stubbs, B
Udgivet: (2016)

Insights into Lipid Metabolism and Composition in Parkinson’s Disease Pathogenesis
af: Pei Xiaoxue, et al.
Udgivet: (2024-11-01)

Degeneration of dopaminergic neurons due to metabolic alterations and Parkinson’s disease
af: Juhyun eSong, et al.
Udgivet: (2016-03-01)

Targeting Glucose Metabolism: A Novel Therapeutic Approach for Parkinson’s Disease
af: Ahmed Tanvir, et al.
Udgivet: (2024-11-01)

Altered substrate metabolism in neurodegenerative disease: new insights from metabolic imaging
af: Nicholas R. W. Cleland, et al.
Udgivet: (2021-10-01)

The Importance of Gut Microbiota on Choline Metabolism in Neurodegenerative Diseases
af: Majid Eslami, et al.
Udgivet: (2024-10-01)

Targeting cardiolipin metabolism for Parkinson's disease therapy
af: Junli Liu, et al.
Udgivet: (2024-12-01)

Endogenous versus exogenous cell replacement for Parkinson’s disease: where are we at and where are we going?
af: Theodora Mourtzi, et al.
Udgivet: (2022-01-01)

Review of Current Human Genome-Scale Metabolic Models for Brain Cancer and Neurodegenerative Diseases
af: Ali Kishk, et al.
Udgivet: (2022-08-01)

Ghrelin: A link between ageing, metabolism and neurodegenerative disorders
af: I.I. Stoyanova
Udgivet: (2014-12-01)

Effect of a physical therapeutic intervention on locomotive syndrome in the elderly patients with Parkinson’s disease and sarcopenia
af: Ivanna V. Didoha, et al.
Udgivet: (2023-03-01)

OPA1 deficiency impairs oxidative metabolism in cycling cells, underlining a translational approach for degenerative diseases
af: Aurélie M. C. Millet, et al.
Udgivet: (2023-09-01)

Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey
af: Paulo J. da Costa, et al.
Udgivet: (2022-01-01)

Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolism
af: Alessio Canovai, et al.
Udgivet: (2025-01-01)

On the Metabolism of Exogenous Ketones in Humans
af: Stubbs, B, et al.
Udgivet: (2017)

On the Metabolism of Exogenous Ketones in Humans
af: Brianna J. Stubbs, et al.
Udgivet: (2017-10-01)

A Ketone Ester Drink Enhances Endurance Exercise Performance in Parkinson’s Disease
af: Nicholas G. Norwitz, et al.
Udgivet: (2020-09-01)

Role of metabolic characteristics in the co-occurrence of insomnia, Alzheimer’s disease, and Parkinson’s disease: a Mendelian randomization study
af: Chengyong Liu, et al.
Udgivet: (2025-01-01)

Mitochondrial Dysfunction in Parkinson’s Disease—Cause or Consequence?
af: Chun Chen, et al.
Udgivet: (2019-05-01)

Exogenous ketone therapy for heart failure: A review
af: Yulia O. Aksenova, et al.
Udgivet: (2023-05-01)

The role of the gut microbiota in neurodegenerative diseases targeting metabolism
af: Yufeng Fu, et al.
Udgivet: (2024-09-01)

Secretome as neuropathology-targeted intervention of Parkinson’s disease
af: Christian Ardianto, et al.
Udgivet: (2022-12-01)

The Metabolism of Coenzyme A and Its Derivatives Plays a Crucial Role in Diseases
af: Jumin Xie, et al.
Udgivet: (2024-04-01)

Ketone metabolism in the heart
af: Bin abdul kadir, A
Udgivet: (2020)

The genetic basis of Parkinson's disease
af: A. A. Tappakhov, et al.
Udgivet: (2017-03-01)

The importance of using methods of selective modification of neuronal function in the pathogenesis and therapy of Parkinson's disease
af: Maciej Superson, et al.
Udgivet: (2024-07-01)

No association between adult height and Parkinson's disease
af: Younggee Jeong, et al.
Udgivet: (2023-01-01)

Impact of tango on Parkinson's disease - a narrative review
af: Magdalena Muzyk, et al.
Udgivet: (2024-08-01)

Pros and cons for statins use and risk of Parkinson's disease: An updated perspective
af: Hayder M. Al‐kuraishy, et al.
Udgivet: (2023-04-01)

Meaning in life and Parkinson’s disease in the UK Biobank
af: Angelina R. Sutin, et al.
Udgivet: (2024-01-01)

Alpha-Synuclein spreading in Parkinson disease
af: Ariadna eRecasens, et al.
Udgivet: (2014-12-01)

Alternative cleavage and polyadenylation of genes associated with protein turnover and mitochondrial function are deregulated in Parkinson’s, Alzheimer’s and ALS disease
af: Radhika Patel, et al.
Udgivet: (2019-05-01)

OX40 Gene and Serum Protein Expression Profiles in Patients with Parkinson’s Disease
af: Azadeh Seyedjoodaki, et al.
Udgivet: (2018-04-01)

Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
af: Srinivasa Reddy Bonam, et al.
Udgivet: (2021-12-01)

The diagnostic reliability of outpatient neurological care to patients with Parkinson’s disease
af: Voskresenskaya O.N., et al.
Udgivet: (2012-06-01)

Editorial: Genetic and Epigenetic Mechanisms of Parkinson's Disease
af: Song Li, et al.
Udgivet: (2022-04-01)

The emerging role of disease-associated microglia in Parkinson’s disease
af: Ritika R. Samant, et al.
Udgivet: (2024-11-01)

Active Immunotherapy for the Prevention of Alzheimer’s and Parkinson’s Disease
af: Madeline M. Vroom, et al.
Udgivet: (2024-08-01)

Anti-Oxidant and Tyrosinase Inhibitory In Vitro Activity of Amino Acids and Small Peptides: New Hints for the Multifaceted Treatment of Neurologic and Metabolic Disfunctions
af: Grazia Luisi, et al.
Udgivet: (2018-12-01)

Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease
af: Berenice A. Gutierrez, et al.
Udgivet: (2022-07-01)